BRPI0408067A - disgnóstico de autismo - Google Patents

disgnóstico de autismo

Info

Publication number
BRPI0408067A
BRPI0408067A BRPI0408067-0A BRPI0408067A BRPI0408067A BR PI0408067 A BRPI0408067 A BR PI0408067A BR PI0408067 A BRPI0408067 A BR PI0408067A BR PI0408067 A BRPI0408067 A BR PI0408067A
Authority
BR
Brazil
Prior art keywords
seq
autism diagnosis
peptides
autism
diagnosis
Prior art date
Application number
BRPI0408067-0A
Other languages
English (en)
Inventor
Anders Grubb
Original Assignee
Naghi Momeni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naghi Momeni filed Critical Naghi Momeni
Publication of BRPI0408067A publication Critical patent/BRPI0408067A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Abstract

"DIAGNóSTICO DE AUTISMO". A presente invenção refere-se a um método de diagnóstico de autismo pela determinação da presença de elevadas concentrações de certos peptídeos analisando-se uma amostra de tecido, uma amostra de fluido corpóreo e/ou uma amostra de plasma com respeito à presença de certos peptídeos que apresentam as seqüências de aminoácidos SKITHRIHWESASLL, SSKITHRIHWESASLL, e SSKITHRIHWESASLLR com as massas moleculares 1779 +/- 1 Da, 1865 +/- 1 Da e 2022 + /- 1 Da, respectivamente.
BRPI0408067-0A 2003-03-04 2004-03-02 disgnóstico de autismo BRPI0408067A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0300586A SE0300586L (sv) 2003-03-04 2003-03-04 Diagnos av autism
PCT/SE2004/000193 WO2004079371A1 (en) 2003-03-04 2004-03-02 Diagnosis of autism

Publications (1)

Publication Number Publication Date
BRPI0408067A true BRPI0408067A (pt) 2006-02-14

Family

ID=20290572

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408067-0A BRPI0408067A (pt) 2003-03-04 2004-03-02 disgnóstico de autismo

Country Status (19)

Country Link
US (1) US8268576B2 (pt)
EP (1) EP1608982B9 (pt)
JP (1) JP4452715B2 (pt)
KR (1) KR101096487B1 (pt)
CN (1) CN1795386B (pt)
AT (1) ATE371192T1 (pt)
AU (1) AU2004217571B2 (pt)
BR (1) BRPI0408067A (pt)
CA (1) CA2518066C (pt)
DE (1) DE602004008439T2 (pt)
DK (1) DK1608982T3 (pt)
ES (1) ES2293234T3 (pt)
NZ (1) NZ542149A (pt)
PL (1) PL1608982T3 (pt)
PT (1) PT1608982E (pt)
RU (1) RU2340900C2 (pt)
SE (1) SE0300586L (pt)
WO (1) WO2004079371A1 (pt)
ZA (1) ZA200507082B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4677556B2 (ja) * 2005-04-22 2011-04-27 国立大学法人 千葉大学 自閉症の診断薬
SG182971A1 (en) * 2007-07-26 2012-08-30 Phenomenome Discoveries Inc Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
WO2012082056A1 (en) 2010-12-16 2012-06-21 Autism Biodiagnosis Ltd. Novel biomarker and uses thereof in diagnosis, treatment of autism
WO2014018468A1 (en) 2012-07-22 2014-01-30 Indiana University Research And Technology Corporation Modulation sapp, sapp alpha and bdnf levels in individuals diagnosed with fxs and asd
US10634677B2 (en) 2013-10-14 2020-04-28 Indiana University Research And Technology Corporation Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and ASD and individuals diagnosed with FXS and ASD
CN105652016A (zh) * 2016-01-28 2016-06-08 深圳大学 一种孤独症检测标志物及其检测方法
KR102083245B1 (ko) 2017-03-10 2020-03-02 스핑고브레인 주식회사 정신장애의 진단 방법
US11131681B2 (en) * 2017-03-10 2021-09-28 Dr. Raymond Laboratories, Inc. Method for diagnosing psychiatric disorders
RU2643760C1 (ru) * 2017-08-07 2018-02-05 Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья" Способ определения необходимости использования психофармакотерапии у пациентов с расстройствами аутистического спектра на момент их обследования
KR20190106442A (ko) 2018-03-09 2019-09-18 스핑고브레인 주식회사 태지, 양수 또는 제대혈을 이용한 정신장애의 진단 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273683A1 (en) * 1998-06-15 1999-12-15 Ortho-Clinical Diagnostics, Inc. Diagnostic markers for human disorders
IT1303675B1 (it) * 1998-08-04 2001-02-23 Radim S P A Metodo di determinazione di peptidi utilizzati come marker per ladiagnosi dell'autismo
JP2003512856A (ja) 1999-11-04 2003-04-08 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ウテログロビン様ポリヌクレオチド、ポリペプチド、および抗体
US6998243B2 (en) 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

Also Published As

Publication number Publication date
NZ542149A (en) 2008-03-28
WO2004079371A1 (en) 2004-09-16
CA2518066A1 (en) 2004-09-16
KR101096487B1 (ko) 2011-12-20
CN1795386A (zh) 2006-06-28
AU2004217571B2 (en) 2009-03-12
RU2005130641A (ru) 2006-02-10
US20120149038A1 (en) 2012-06-14
RU2340900C2 (ru) 2008-12-10
ZA200507082B (en) 2007-02-28
AU2004217571A1 (en) 2004-09-16
KR20060006774A (ko) 2006-01-19
JP4452715B2 (ja) 2010-04-21
EP1608982A1 (en) 2005-12-28
JP2006519391A (ja) 2006-08-24
SE0300586L (sv) 2004-09-05
ES2293234T3 (es) 2008-03-16
EP1608982B9 (en) 2008-07-23
CA2518066C (en) 2011-05-10
PT1608982E (pt) 2007-11-09
DK1608982T3 (da) 2007-11-26
SE0300586D0 (sv) 2003-03-04
EP1608982B1 (en) 2007-08-22
PL1608982T3 (pl) 2008-01-31
DE602004008439D1 (de) 2007-10-04
ATE371192T1 (de) 2007-09-15
DE602004008439T2 (de) 2008-05-21
CN1795386B (zh) 2010-08-25
US8268576B2 (en) 2012-09-18

Similar Documents

Publication Publication Date Title
ATE410178T1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
IL129299A0 (en) Monoclonal antibodies antigens and diagnosis of malignant diseases
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
BRPI0408067A (pt) disgnóstico de autismo
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
WO2004043223A3 (en) Compositions and methods for the diagnosis and treatment of sepsis
DE602005012530D1 (de) Immunogene glykopeptide zur diagnose von infektionen pathogener mikroorganismen
ATE547523T1 (de) Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
TR200200667T2 (tr) Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları.
CA2366523A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
WO2004070012A3 (en) Cell-killing molecules and methods of use thereof
EP2290093A3 (fr) Procédé de détection de la PRP utilisant une molécule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
GB0223655D0 (en) Method of diagnosis
WO2010128232A3 (fr) Méthode de diagnostic des infections à propionibacterium acnes
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
ATE420210T1 (de) Diagnose des brustkrebsrisikos
PT1527197E (pt) Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização
FR2922213B1 (fr) Polymeres a empreintes moleculaires pour la reconnaissance du glutathion gsh, leurs procede de preparation et utilisations
WO2002074793A3 (en) Novel peptides for the diagnosis of schizophrenia
UA49752A (uk) Спосіб визначення концентрації пентапептидного аналога вазопресину у водному розчині
TH76284A (th) เพปไทด์ของเอพสไทน์บาร์ไวรัส (ebv) และวิธีการสำหรับการวินิจฉัยโรคที่เกี่ยวข้องกับ ebv

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.